Paper870132
Tumour regression as a guide to prognosis: a study with experimental animals.
Denekamp J. Br J Radiol, 1977. Cited by 52 papers, by iCite.
Cite this record
ConductScience Library. Tumour regression as a guide to prognosis: a study with experimental animals. Papers, record 870132. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/870132
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Mammary Neoplasms, Experimental | Major topic |
| Animals | |
| Dose-Response Relationship, Radiation | |
| Humans | |
| Hyperbaric Oxygenation | |
| Mice | |
| Mice, Inbred C3H | |
| Neoplasm Recurrence, Local | |
| Neoplasm Transplantation | |
| Radiation Tolerance |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 26792490 | Advanced Small Animal Conformal Radiation Therapy Device. | Technol Cancer Res Treat | 2017 | https://conductscience.org/library/papers/26792490 | PubMed |
| 15912426 | In vivo follow-up of rat tumor models with 2-deoxy-2-[F-18]fluoro-D-glucose/dual-head coincidence gamma camera imaging. | Mol Imaging Biol | 2005 | https://conductscience.org/library/papers/15912426 | PubMed |
| 9198910 | [A reply to the comment by K. R. Trott in Strahlenther. Onkol. 173 (1997), 146-147 on the article by Strnad et al.: "The regression of Yoshida sarcoma during normoxia and hypoxia after fractionated irradiation" in Strahlenther. Onkol. 173 (1997), 141-145]. | Strahlenther Onkol | 1997 | https://conductscience.org/library/papers/9198910 | PubMed |
| 9122854 | [Regression of Yoshida sarcoma during normoxia and hypoxia after fractionated irradiation]. | Strahlenther Onkol | 1997 | https://conductscience.org/library/papers/9122854 | PubMed |
| 7000126 | Can dose-survival parameters be deduced from in situ assays? | Br J Cancer Suppl | 1980 | https://conductscience.org/library/papers/7000126 | PubMed |
| 7000125 | Is any single in situ assay of tumour response adequate? | Br J Cancer Suppl | 1980 | https://conductscience.org/library/papers/7000125 | PubMed |
| 7000117 | Assessment of the response of tumours to radiation: clinical and experimental studies. | Br J Cancer Suppl | 1980 | https://conductscience.org/library/papers/7000117 | PubMed |
| 552471 | Regression, recurrence and cure in an irradiated mouse tumour. | J R Soc Med | 1979 | https://conductscience.org/library/papers/552471 | PubMed |
| 277243 | Sensitization of mouse tumours using fractionated X-irradiation. | Br J Cancer Suppl | 1978 | https://conductscience.org/library/papers/277243 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/870132
GET https://conductscience.org/api/papers/v1/870132/authors